Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

pfizer private limited - ampicillin sodium eqv ampicillin; sulbactam sodium eqv sulbactam - injection, powder, for solution - 1 g/vial - ampicillin sodium eqv ampicillin 1 g/vial; sulbactam sodium eqv sulbactam 500 mg/vial

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

pfizer private limited - ampicillin sodium eqv ampicillin; sulbactam sodium eqv sulbactam - injection, powder, for solution - 2 g/vial - ampicillin sodium eqv ampicillin 2 g/vial; sulbactam sodium eqv sulbactam 1 g/vial

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

pfizer private limited - ampicillin sodium eqv ampicillin; sulbactam sodium eqv sulbactam - injection, powder, for solution - 500 mg/vial - ampicillin sodium eqv ampicillin 500 mg/vial; sulbactam sodium eqv sulbactam 250 mg/vial

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

the cathay drug co., inc. - ampicillin (as sodium) , sulbactam (as sodium) - powder for injection (i.m./i.v.) - 1 g/ 500 mg

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

the cathay drug co., inc. - ampicillin (as sodium) , sulbactam (as sodium) - powder for injection (im/iv) - 250mg/ 125mg

Φιλιππίνες - Αγγλικά - FDA (Food And Drug Administration)

the cathay drug co., inc. - ampicillin (as sodium) , sulbactam (as sodium) - powder for injection (im/iv) - 500mg/ 250mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

lajolla pharmaceutical company - sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - xacduro is indicated in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (habp/vabp), caused by susceptible isolates of acinetobacter baumannii-calcoaceticus complex. limitations of use xacduro is not indicated for the treatment of habp/vabp caused by pathogens other than susceptible isolates of acinetobacter baumannii-calcoaceticus complex [see clinical studies (14)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of xacduro and other antibacterial drugs, xacduro should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. xacduro is contraindicated in patie

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

mylan pharmaceuticals pte. ltd. - ampicillin sodium 1.063g equivalent to ampicillin; sulbactam sodium 0.547g equivalent to sulbactam - injection, powder, for solution - 1.0g - ampicillin sodium 1.063g equivalent to ampicillin 1.0g; sulbactam sodium 0.547g equivalent to sulbactam 0.5g

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

mylan pharmaceuticals pte. ltd. - ampicillin sodium 2.126g equivalent to ampicillin; sulbactam sodium 1.094g equivalent to sulbactam - injection, powder, for solution - 2.0g - ampicillin sodium 2.126g equivalent to ampicillin 2.0g; sulbactam sodium 1.094g equivalent to sulbactam 1.0g